← Eichor
Condition: Cns Lymphoma Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Cns Lymphoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

CLIMB: CNS Lymphoma Imaging and Molecular Biomarkers Study
Phase N/A · 1 location(s) · Royal Marsden NHS Foundation Trust · NCT05828628The "Let's Talk Tech" Tool to Support Decision Making About Technology Use
NA · 1 location(s) · University of Washington · NCT06817122A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease P
Phase 2 · 2 location(s) · Elixiron Immunotherapeutics Inc. · NCT06745583Tafasitamab Plus Lenalidomide in Relapsed CNS Lymphoma
Phase 1/Phase 2 · 1 location(s) · James Rubenstein · NCT05351593A Study of MB-CART19.1 Cellular Therapy for People With Central Nervous System Lymphoma (CNSL)
Phase 1 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT07137494Testing the Addition of Lenalidomide and Nivolumab to the Usual Treatment for Primary CNS Lymphoma
Phase 1 · 55 location(s) · National Cancer Institute (NCI) · NCT04609046Selinexor in Combination With MTX+Ritu to Treat R/R CNSL
Phase 1/Phase 2 · 5 location(s) · Tong Chen, MD · NCT05698147Cognitive Screening Made Easy for PCPs - Administrative Supplement
NA · 3 location(s) · University of Texas at Austin · NCT06928298A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplan
Phase 2 · 40 location(s) · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company · NCT07015242The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
Phase 1/Phase 2 · 11 location(s) · AVM Biotechnology Inc · NCT04329728Multicentre Implementation and Validation of a Molecular Diagnostic for VitreoRetinal Lymphoma
Phase N/A · 1 location(s) · Vinodh Kakkassery, MD · NCT05841914Therapeutic Effects of R-IDARAM and Intrathecal Immunochemotherapy on Elderly Patients With PCNSL
Phase 2/Phase 3 · 1 location(s) · Navy General Hospital, Beijing · NCT02836158At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
Phase 2 · 2 location(s) · Mayo Clinic · NCT05969860GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)
Phase 3 · 8 location(s) · The Affiliated Nanjing Drum Tower Hospital of Nanjing Univer · NCT07083154CtDNA for Early Response Assessment in PCNSL Treated with 1st Line Curative Intent (NLG-PCNSL-01)
Phase N/A · 5 location(s) · Nordic Lymphoma Group · NCT06755619Preliminary Safety and Tolerability of CD19x22 CAR T Cells in Adolescent and Adult R/R B-NHL Patients
Phase 1 · 1 location(s) · University of Colorado, Denver · NCT05098613Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Parti
Phase 2 · 7 location(s) · Providence Health & Services · NCT06175000A Study of Selinexor in Combination With Temozolomide and Anti-PD-1 Antibody in Patients With Relapsed/Refractory Primar
Phase 1/Phase 2 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT06556199Liquid Biopsy Evaluation and Repository Development at Princess Margaret
Phase N/A · 1 location(s) · University Health Network, Toronto · NCT03702309Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies
Phase N/A · 1 location(s) · M.D. Anderson Cancer Center · NCT05011045CNS-Relapse Prevention in High-Risk Diffuse Large B-cell Lymphoma With Thiotepa-based Autologous Stem Cell Transplant
Phase 2 · 1 location(s) · Washington University School of Medicine · NCT06687772The DANCEREX Proof-of-Concept Study for Chronic Neurological Disorders
NA · 3 location(s) · Fondazione Don Carlo Gnocchi ETS · NCT06112639A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06736613Feasibility of Acquiring Hyperpolarized Imaging in Patients With Primary CNS Lymphoma
Phase 1 · 1 location(s) · James Rubenstein · NCT04656431Q702 for the Treatment of Patients With Hematologic Malignancies
Phase 1 · 2 location(s) · Mayo Clinic · NCT06712810B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021
Phase 4 · 1 location(s) · Federal Research Institute of Pediatric Hematology, Oncology · NCT05518383SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Phase N/A · 68 location(s) · Massive Bio, Inc. · NCT03452774Pain With Dementia
NA · 1 location(s) · Duke University · NCT06854718Safety and Efficacy of Enhanced Recovery After Surgery in Neurocritical Care
NA · 1 location(s) · Shanghai 6th People's Hospital · NCT06241482Paper-Based and Smartphone-Based Memory Supports
NA · 3 location(s) · Baylor University · NCT06444841
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.